Severity or Etiology? ― Reframing Cardiogenic Shock Management in the Era of Individualized Mechanical Circulatory Support ―
priate?These decisions involve a delicate trade-off between timeliness, hemodynamic cost, and complication risks.Despite several consensus statements from Japan, 1 W hen encountering patients with cardiogenic shock (CS), clinicians face complex decisions regarding the initiation and management of temporary mechanical circulatory support (tMCS): Should pharmacological therapy be attempted first?Should tMCS be initiated early?If so, which device is most appro-
Authors
- Takahiro Nakashima
Institutions
- Kumamoto University (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1253/circj.cj-25-1037
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00